The IMARC Group provides extensive analysis of the point-of-care diagnostics industry covering the market trends, investment opportunities, growth trends, statistics, and industry prospects. The report offers a comprehensive analysis of the industry, which comprises insights on point-of-care diagnostics market size, share, trends, analysis, growth, demand, statistics, and overview. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. The market is segmented by size and region. The report provides an analysis of the key trends in each sub-segment of the market, along with forecasts at the global and regional level from 2022-2027. The report also includes competitive landscape of major key players in the industry along with emerging trends in the market.
Informed covered in the report:
- Historical market data from 2016-2021
- CAGR of the market during the forecast period 2022-2027
- Detailed information on factors that will drive market growth during the next five years
- Precise estimation of the Keyword market size and its contribution to the parent market
- Upcoming market trends and changes in consumer behavior
- A thorough analysis of the market’s competitive landscape and detailed information on key players
- Comprehensive details of factors that will challenge the growth of smart meters market key players
The global point-of-care diagnostics market size reached US$ 41.1 Billion in 2021. Point-of-care (PoC) diagnostics include the medical testing conducted to obtain a quick diagnosis and instant detection of critical illnesses. PoC testing uses several portable instruments for glucose monitoring and detection of infectious disease, cardiometabolic, urinalysis, etc. It also aids in delivering diagnostic facilities to remote locations where setting up a clinical laboratory is challenging. The testing equipment is often integrated with medical vehicles, including helicopters, air ambulances, airplanes, and spacecraft.
Point-of-Care Diagnostics Market Trends:
The high prevalence of chronic diseases, along with the rising geriatric population, is augmenting the demand for point-of-care (PoC) diagnostics. Moreover, technological advancements have led to the development of miniaturized devices, thereby driving the market growth. Furthermore, rapid integration with PoC devices with wireless technology has enabled healthcare professionals to maintain electronic medical records (EMR). These records facilitate the direct transmission of test results from PoC devices to the lab specialists, thus reducing the chances of discrepancies. The market is further propelled by the inclusion of home-testing cancer kits to monitor and analyze tumor cells. Besides this, rising R&D activities to develop molecular diagnostic devices and the growing demand for early disease detection are anticipated to boost the point-of-care (PoC) diagnostics market. Looking forward, IMARC Group expects the point-of-care diagnostics market to reach US$ 69.4 Billion by 2027, exhibiting a growth rate (CAGR) of 9.06% during 2022-2027.
Checkout Now: https://www.imarcgroup.com/checkout?id=2113&method=1
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
- Abbott Laboratories
- Beckman Coulter Inc.
- Becton
- Dickinson and Company
- Hoffmann-La Roche AG
- Instrumentation Laboratory
- Johnson & Johnson
- Nova Biomedical Corporation
- Pts Diagnostics
- Qiagen
- Siemens
- Trinity Biotech
- Blood-Glucose Monitoring Kit
- Cardio-Metabolic Monitoring Kit
- Pregnancy and Fertility Testing Kit
- Infectious Disease Testing Kit
- Cholesterol Test Strip
- Hematology Testing Kit
- Others
Breakup by Platform:
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular Diagnostics
- Immunoassays
- Prescription-Based Testing
- OTC Testing
- Professional Diagnostic Centers
- Home Care
- Research Laboratories
- Others
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800